DayOne accelerator

What DayOne accelerator does

DayOne Accelerator is a Basel, Switzerland-based accelerator programme targeting early-stage healthtech and techbio startups whose products address pharmaceutical research and development. Founded in 2018 and operating with 1-10 employees, the programme runs a three-month hybrid cohort model selecting 15 startups per cycle and recruits founders through an open global application process. The core offering, the DayOne Accelerator Programme, provides mentorship, industry access, and connections to Basel's established life sciences and pharma ecosystem, positioning itself as a bridge between early-stage founders and the regional pharma cluster.

The business model is structurally distinct from conventional accelerators: participation is equity-free and fee-free, meaning selected startups are not charged fees and the accelerator does not take equity in exchange for programme participation. DayOne supplements the core offering with a follow-on module called DayOne NEXT, which provides graduates with up to CHF 100,000 in grant funding along with services to support further development. This grant-based, non-dilutive capital structure shifts the economic model away from equity optionality toward sponsor, public, or institutional funding for the accelerator itself, the specific sources of which are not disclosed in available data.

The programme's competitive positioning rests on its anchoring in the Basel life sciences cluster, which hosts a dense concentration of pharma headquarters, research institutions, and corporate venture activity. This geographic specialization limits DayOne's addressable market but deepens its relevance to founders building pharma R&D tooling, digital health, and techbio products. DayOne serves as a branded sub-programme within the broader DayOne initiative and is led in part by a Director of Healthtech Innovation & Investment, indicating dedicated investment-focused leadership within the operating team.

Name

DayOne accelerator

Legal name

DayOne Accelerator

Website

https://dayone.swiss

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

1–10 employees

Short description

DayOne Accelerator is a Basel-based equity- and fee-free three-month hybrid accelerator for early-stage healthtech and techbio startups building pharma R&D solutions, selecting 15 startups per cohort and offering a follow-on DayOne NEXT module with up to CHF 100,000 in grants.

Ownership category

akta.pro rank

Product category

Startup Accelerator

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Computer Programming Services (7371)

akta.pro primary industry

Accelerator / Incubator-Backed ETA Programs (FSANALAD)

akta.pro secondary industry

Accelerators & Incubators (Investor-Operated) (FSANAAAM)

Keywords

• Healthtech accelerator programmes
• Techbio startup acceleration
• Pharma R&D innovation
• Life sciences venture support
• Startup mentorship programmes

Headquarters

HQ city

Basel

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Distribution channels1 record

Core offering

DayOne Accelerator runs a three-month hybrid accelerator programme for early-stage healthtech and techbio startups developing solutions for pharmaceutical R&D, providing mentorship, industry access, and connections to Basel's life sciences ecosystem. The programme is equity-free and fee-free, selecting 15 startups per cohort. Selected graduates can also apply to DayOne NEXT, a follow-on programme offering up to CHF 100,000 in grant funding and services.

Product overview

DayOne Accelerator is a Basel, Switzerland-based accelerator programme for early-stage healthtech and techbio startups. The core offering is the three-month hybrid DayOne Accelerator Programme, which is equity-free and fee-free, providing mentorship, industry access, and connections to the Basel's life sciences ecosystem. An optional follow-on programme called DayOne NEXT offers grant funding of up to CHF 100,000 along with services for graduates of the accelerator.

Differentiator

Problem solved

Functional benefit

Brands

• DayOne NEXT: A follow-on programme offering up to CHF 100,000 in grant funding and services to selected startups from the main accelerator programme.

Products and services

• DayOne Accelerator Programme

Segments2 records

Ideal customer profiles2 records

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• BioInnovation Institute (BII): Copenhagen-based life sciences and healthtech accelerator/incubator offering创业 support, lab space, and convertible-note funding to early-stage biotech, healthtech, and pharma R&D startups. Directly comparable to DayOne in vertical focus (life sciences / pharma R&D) and stage (early-stage), with a similarly grant-backed funding model.
• IndieBio (SOSV): SOSV-operated biotech accelerator (NY and San Francisco) investing in early-stage biology-based startups via accelerator cohorts and follow-on funding. Comparable to DayOne in techbio/biology vertical and cohort-based programme structure, though takes equity where DayOne does not.
• Bayer Co.Lab (formerly G4A): Bayer's global pharma and healthtech accelerator with offices in Berlin, Shanghai, Boston, and São Paulo. Comparable to DayOne in targeting early-stage healthtech and pharma R&D startups, though operating at significantly larger scale and as a corporate-backed programme.
• MassChallenge HealthTech: Boston-based equity-free healthtech accelerator partnering with major hospitals, payers, and pharma companies to support early-stage digital health startups. Comparable to DayOne in equity-free model, healthtech vertical, and pharma R&D piloting focus.
• Startupbootcamp Digital Health: Now part of Rainmaking, this digital health accelerator has run cohorts in Europe targeting early-stage healthtech and pharma-adjacent startups. Comparable in vertical focus and accelerator model, though historically shorter on dedicated life sciences lab access than DayOne.
• Novartis Biome: Novartis's digital health innovation hub connecting healthtech startups with pharma R&D and commercial teams. Direct peer because it serves early-stage healthtech founders targeting pharma integration, with comparable mentor/pharma-access value proposition to DayOne.
• Roche Accelerator: Roche-operated in-house accelerator based in Basel serving healthtech and techbio startups with direct pharma R&D collaboration. Most direct local competitor because it shares DayOne's Basel base and pharma R&D focus, and offers much larger enterprise resources.

Emerging players

• MBC BioLabs: San Francisco-based biotech incubator providing fully equipped lab space and structured programmes to early-stage life sciences startups. Comparable to DayOne in supporting early-stage science-driven startups, though it focuses on physical lab infrastructure rather than pharma R&D piloting.
• Sanofi i2i (Innovation & Investment Initiative): Sanofi's external innovation and venture arm supporting early-stage healthtech and biotech startups through pilots, partnerships, and minority investment. Comparable as a pharma-sponsored channel for healthtech founders, though structured as a corporate CVC/venture arm rather than a classical accelerator.

Broad incumbents

• EIT Health Accelerator: Pan-European healthtech accelerator network funded by the European Institute of Innovation & Technology. Comparable as a healthtech/pharma R&D accelerator operating across Europe with publicly-backed funding mechanisms, though much broader in scope and geography than DayOne.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments53 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DayOne accelerator